Wednesday, July 8, 2026

pharma · Acne Rosacea · Atopic Dermatitis · DRMA

Dermata Therapeutics

Dermata Therapeutics clinical programs — 3 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

San Diego, USA HQ
2014 Founded
12 Employees
Public company Type
DRMA · NYSE Ticker
Company details
Status
Public
HQ
San Diego, USA
Founded
2014
Employees
12
Programs
4
Drugs
2
Patents
30
Intelligence · Clinical Programs

Dermata Therapeutics projects

3 ClinicalTrials.gov programs sponsored by Dermata Therapeutics.

Dermata Therapeutics has 3 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. DMT210 Topical Gel

    Dermata Therapeutics

    Atopic Dermatitis

    phase 2 small molecule completed

    1 trial
  2. DMT210 Topical Gel 5%

    Dermata Therapeutics

    Acne Rosacea

    phase 2 small molecule completed

    1 trial
  3. Topical Powder

    Dermata Therapeutics

    Acne Rosacea

    phase 2 small molecule active

    1 trial

Frequently asked questions

How many clinical projects does Dermata Therapeutics have?

3 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.